Manifold MarketsSin KYCDatos de resolución verificadosCalibración aceptable
Pronóstico comunitario actual
No 79.3%
Pronosticadores
47
Tipo de pregunta
binary
Metodología
Play-money forecasting platform
Tipo de fuente
Pronóstico
Datos de mercado
Actualizado hace 4 horas
Desactualizado
23 dic 22, 2:32 UTC31 dic 30, 23:59 UTC
Tendencias
Resultado24hProbabilidad
Reglas
Many people do not currently see gene editing to cure e.g., cancer, sickle-cell, or down syndrom as a clear moral good that humanity should be persuing.
Will this change by 2030?
Currently, I count ~40% of the most recent tweets containing the term "gene editing" as clearly negative; "gene therapy" is much, much worse.
Twitter may not be the most approprite source by time of resolution, but I will try to find a broadly equivalnt source of popular opinion.
When I look at statements of popular opinion, will at least 90% be positive or neutral? By default, I will treat technical statements of valid research as neutral, even if they show negative results or document risks.
I will search for whatever term or terms are most commonly used in 2030.
¿Cuáles son las probabilidades actuales de By 2030, will gene editing to cure serious genetic diseases be seen as generally uncontroversial??
Manifold Markets cotiza No al 79% a fecha de 8 de septiembre de 2026.
¿Cuándo se resuelve By 2030, will gene editing to cure serious genetic diseases be seen as generally uncontroversial??
Está previsto que By 2030, will gene editing to cure serious genetic diseases be seen as generally uncontroversial? se resuelva el 31 de diciembre de 2030.
¿Cómo se liquida By 2030, will gene editing to cure serious genetic diseases be seen as generally uncontroversial??
Manifold Markets liquida este mercado del siguiente modo: Many people do not currently see gene editing to cure e.g., cancer, sickle-cell, or down syndrom as a clear moral good that humanity should be persuing.